These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10542254)
21. The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination. Thalappilly S; Feng X; Pastyryeva S; Suzuki K; Muruve D; Larocque D; Richard S; Truss M; von Deimling A; Riabowol K; Tallen G PLoS One; 2011; 6(6):e21065. PubMed ID: 21731648 [TBL] [Abstract][Full Text] [Related]
22. The role of the tumour suppressor p33 ING1b in human neoplasia. Nouman GS; Anderson JJ; Lunec J; Angus B J Clin Pathol; 2003 Jul; 56(7):491-6. PubMed ID: 12835293 [TBL] [Abstract][Full Text] [Related]
23. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695 [TBL] [Abstract][Full Text] [Related]
24. Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). Kuzmichev A; Zhang Y; Erdjument-Bromage H; Tempst P; Reinberg D Mol Cell Biol; 2002 Feb; 22(3):835-48. PubMed ID: 11784859 [TBL] [Abstract][Full Text] [Related]
25. Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. Goeman F; Thormeyer D; Abad M; Serrano M; Schmidt O; Palmero I; Baniahmad A Mol Cell Biol; 2005 Jan; 25(1):422-31. PubMed ID: 15601862 [TBL] [Abstract][Full Text] [Related]
26. Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis. Coles AH; Liang H; Zhu Z; Marfella CG; Kang J; Imbalzano AN; Jones SN Cancer Res; 2007 Mar; 67(5):2054-61. PubMed ID: 17332334 [TBL] [Abstract][Full Text] [Related]
27. UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences. Scott M; Boisvert FM; Vieyra D; Johnston RN; Bazett-Jones DP; Riabowol K Nucleic Acids Res; 2001 May; 29(10):2052-8. PubMed ID: 11353074 [TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma. Igci M; Arslan A; Erturhan S; Igci YZ; Pala E; Gogebakan B; Karakok M; Cakmak EA; Cengiz B Mol Biol Rep; 2015 Feb; 42(2):507-16. PubMed ID: 25324173 [TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor ING1: structure and function. Cheung KJ; Li G Exp Cell Res; 2001 Aug; 268(1):1-6. PubMed ID: 11461112 [TBL] [Abstract][Full Text] [Related]
31. Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas. Kichina JV; Zeremski M; Aris L; Gurova KV; Walker E; Franks R; Nikitin AY; Kiyokawa H; Gudkov AV Oncogene; 2006 Feb; 25(6):857-66. PubMed ID: 16170338 [TBL] [Abstract][Full Text] [Related]
32. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells. Shimada H; Liu TL; Ochiai T; Shimizu T; Haupt Y; Hamada H; Abe T; Oka M; Takiguchi M; Hiwasa T Oncogene; 2002 Feb; 21(8):1208-16. PubMed ID: 11850840 [TBL] [Abstract][Full Text] [Related]
33. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Vieyra D; Toyama T; Hara Y; Boland D; Johnston R; Riabowol K Cancer Res; 2002 Aug; 62(15):4445-52. PubMed ID: 12154053 [TBL] [Abstract][Full Text] [Related]
34. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. Tamannai M; Farhangi S; Truss M; Sinn B; Wurm R; Bose P; Henze G; Riabowol K; von Deimling A; Tallen G Oncol Res; 2010; 18(10):469-80. PubMed ID: 20681406 [TBL] [Abstract][Full Text] [Related]
35. Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity. Ohgi T; Masaki T; Nakai S; Morishita A; Yukimasa S; Nagai M; Miyauchi Y; Funaki T; Kurokohchi K; Watanabe S; Kuriyama S Scand J Gastroenterol; 2002 Dec; 37(12):1440-8. PubMed ID: 12523595 [TBL] [Abstract][Full Text] [Related]
36. [p33(ING1) gene expression and mutation in stomach cancer tissues and precarcinomatous tissues]. Ding HZ; Yang D; Wu FR; Li H; Feng K; Zheng SJ; Ni CR; Yu GZ Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):320-3. PubMed ID: 12812652 [TBL] [Abstract][Full Text] [Related]
37. Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues. Nouman GS; Angus B; Lunec J; Crosier S; Lodge A; Anderson JJ Hybrid Hybridomics; 2002 Feb; 21(1):1-10. PubMed ID: 11991811 [TBL] [Abstract][Full Text] [Related]
38. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34. Zeremski M; Horrigan SK; Grigorian IA; Westbrook CA; Gudkov AV Somat Cell Mol Genet; 1997 May; 23(3):233-6. PubMed ID: 9330636 [TBL] [Abstract][Full Text] [Related]
39. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961 [TBL] [Abstract][Full Text] [Related]
40. Generation of a polyclonal antibody specifically against the p33(ING1b) tumor suppressor. Campos EI; Xiao H; Li G J Immunoassay Immunochem; 2004; 25(1):71-80. PubMed ID: 15038618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]